A multicenter randomized controlled trial of crosslinked sodium hyaluronate gel for the prevention of adhesion after hysteroscopic electrocision

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047165

Enrollment

Unknown

Registered

2021-06-09

Start date

2018-06-01

Completion date

Unknown

Last updated

2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine disease

Interventions

experimental group:crosslinked sodium hyaluronate gel

Control Group:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with submucosal myoma, polypectomy and mediastinal hysterectomy by hysteroscopy; 2. Aged 18-55 years; 3. Clinical and laboratory tests showed normal liver and kidney function; 4. No serious systemic disease 5. Get informed consent to participate in the study and agree to take contraceptive measures within 3 months after surgery; 6. Good compliance, willing and able to follow up and observe as required after surgery.

Exclusion criteria

Exclusion criteria: 1. Weight > 100 kg; 2. Postmenopausal women (FSH > 40 mIU/ml, estradiol <20 pg/ml), pregnant women; 2. Patients with intrauterine adhesions; 3. Pelvic inflammation, reproductive tract malignancy and other systemic diseases causing abnormal uterine bleeding, postmenopausal women.

Design outcomes

Primary

Measure	Time frame
Score of intrauterine adhesions;	—

Secondary

Measure	Time frame
rate of pregnancy;menstrual blood volume;	—

Countries

China

Contacts

Public ContactTan Xin

West China Second Hospital, Sichuan University

tan8336@icloud.com+86 13568808828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026